Radical prostatectomy versus radiation therapy for clinically localized prostate carcinoma: The butcher and the baker selling their wares

Cancer

Volumn 95, Issue 2, 2002, Pages 211-214

  Moul, Judd W ^a,b,c  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b Center for Prostate Disease Research   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; COMPARATIVE STUDY; HUMAN; MALE; MEDICAL SPECIALIST; ONCOLOGY; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; REVIEW; SURGEON;

HUMANS; MALE; PROSTATECTOMY; PROSTATIC NEOPLASMS; SURVIVAL RATE;

EID: 0037099724     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10658     Document Type: Review

References (17)

1. Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era
2. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer
3. Prostate cryotherapy: Ultrasonographic and pathologic correlation in the Canine model
4. Consensus statement: Guidelines for PSA following radiation therapy
5. Defining prostate specific antigen progression after radical prostatectomy: What is the most appropriate cut point?
6. The definition of biochemical failure in patients treated with definitive radiotherapy
7. Radical surgery versus radiotherapy for adenocarcinoma of prostate
8. Population-based study of long-term survival in patients with clinically localized prostate cancer
9. Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostatectomy, external beam radiotherapy, or expectant management: A retrospective analysis
10. Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life: A structured debate
11. Cancer control with radical prostatectomy alone in 1,000 consecutive patients
12. Stage T1-2 prostate cancer with pretreatment prostate-specific antigen level < or = 10 ng/ml: Radiation therapy or surgery?
13. A comparison of beam radiation therapy versus radical prostatectomy for patients with low risk prostate carcinoma diagnosed, staged, and treated at a single institution
14. Radiation therapy for clinically localized prostate cancer: A multi-institutional pooled analysis
15. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin
16. The CaPSURE database: A methodology for clinical practice and research in prostate cancer
17. Introduction to Department of Defense Center for Prostate Disease Research Multicenter National Prostate Cancer Database and analysis of changes in the PSA-Era